News
For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Bronchitol Paediatric Cystic Fibrosis Clinical Trial Reports Positive Results
Pharmaceutical research company Pharmaxis (ASX: PXS) is pleased to announce positive results of its recently completed Phase II trial of Bronchitol® (mannitol) in children and adolescents with cystic fibrosis (CF). The trial, conducted across 39 global centres, met its primary endpoint and confirms that Bronchitol is efficacious in young patients, regardless of concomitant dornase alfa use.
Read full media release - pdfPharmaxis in the News - 15 December 2015
Bennelong Innovation Forum
Pharmaxis CEO Gary Phillips was a key speaker at the inaugural Bennelong Innovation Forum attended by the Minister for Health, Sussan Ley, at Macquarie University on 9 December.
Gary told an audience of more than 400 attendees how Pharmaxis has grown through innovation and partnering.
The Australian
Pharmaxis CEO Gary Phillips speaks to The Australian about policy to support the commercialisation of biomedical research.
Read full media release - pdf